qXR-CTR vs Eko Low Ejection Fraction Tool (ELEFT)
AI Verdict
Choose qXR-CTR if…
Choose qXR-CTR if your clinical workflow involves routine chest X-ray imaging and you require an automated, objective assessment of heart size to identify potential cardiac enlargement. This tool is ideal for radiology departments or clinics seeking to streamline the initial screening for heart failure risk based on existing imaging data.
View qXR-CTR →Choose Eko Low Ejection Fraction Tool (ELEFT) if…
Choose Eko Low Ejection Fraction Tool (ELEFT) if you need a rapid, non-invasive screening solution for low ejection fraction during routine physical examinations. This tool is particularly well-suited for primary care physicians or cardiologists looking to proactively identify patients at risk for heart failure at the point of care, facilitating earlier intervention and referral.
View Eko Low Ejection Fraction Tool (ELEFT) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | qXR-CTR | Eko Low Ejection Fraction Tool (ELEFT) |
|---|---|---|
| Deployment | Can be deployed on cloud or on-premise. The Qure.ai app receives DICOM studies via DICOM network protocol from medical systems (PACS/Modality) or can import DICOM from the local system. The received DICOM study is processed in Qure's cloud server, and AI-processed reports are displayed on the app. | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Low Ejection Fraction Tool (ELEFT)Eko Low Ejection Fraction Tool (ELEFT) integrates directly with Eko digital stethoscopes, providing real-time results in approximately 15 seconds during routine physical exams. This offers immediate insights at the point of care, seamlessly fitting into existing clinical workflows for direct patient interaction. In contrast, qXR-CTR processes existing X-ray images, which is a common but less real-time workflow.
Clinical Value
Eko Low Ejection Fraction Tool (ELEFT)ELEFT aids in the early detection of low ejection fraction, a key and direct indicator of heart failure, during routine physical exams. This proactive screening at the point of care offers significant clinical value for early intervention and improved patient outcomes. While qXR-CTR assesses heart size and potential heart failure risk from X-rays, ELEFT's focus on a direct physiological indicator during a routine exam provides a more immediate and actionable clinical insight.
Pricing & Value
TieBoth qXR-CTR and Eko Low Ejection Fraction Tool (ELEFT) require potential customers to contact their respective sales teams for pricing details. Neither company publicly discloses specific pricing information, making a direct comparison of their pricing and overall value proposition impossible without further inquiry.
Enterprise Readiness
qXR-CTRqXR-CTR offers flexible deployment options including cloud, on-premise, and hybrid models, which can cater to a wider range of enterprise IT infrastructures and security preferences. Both tools are FDA cleared, HIPAA compliant, and offer Business Associate Agreements (BAAs), demonstrating strong regulatory and compliance readiness for enterprise adoption.
Innovation
Eko Low Ejection Fraction Tool (ELEFT)Eko Low Ejection Fraction Tool (ELEFT) demonstrates greater innovation by integrating an AI algorithm with a traditional clinical tool, the digital stethoscope, for real-time, non-invasive detection of low ejection fraction during routine physical exams. This represents a novel application of AI at the point of care. qXR-CTR, while valuable, automates a measurement from an existing imaging modality, which is a more established application of AI in radiology.
Support & Docs
Eko Low Ejection Fraction Tool (ELEFT)Eko Health provides a comprehensive and publicly accessible Help Center with user manuals, FAQs, and various contact options including live Q&A sessions, 1:1 phone calls, email support, and a support ticket system with a stated 24-hour follow-up. Qure.ai also offers dedicated client success partners, email support with a less than 6-hour response time, and in-app support, along with user manuals and API documentation. However, Eko's public-facing support resources appear more extensive and readily available.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | qXR-CTR | Eko Low Ejection Fraction Tool (ELEFT) |
|---|---|---|
| Tool Name | qXR-CTR | Eko Low Ejection Fraction Tool (ELEFT) |
| Company | Qure.ai Technologies | Eko Health |
| Core Function | AI-powered software that automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images, aiding in the assessment of heart size and potential heart failure risk. | FDA-cleared AI algorithm that integrates with Eko digital stethoscopes to aid clinicians in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams. |
| Tagline | AI-powered Chest X-ray Solution for Automated Cardiothoracic Ratio Assessment. | Your new partner in precise, proactive heart and lung care. |
| Primary Data Source/Integration | Chest X-ray images | Eko digital stethoscopes (analyzes ECG and heart sound recordings) |
Videos
Demos, reviews, and walkthroughs featuring qXR-CTR and Eko Low Ejection Fraction Tool (ELEFT).
Frequently Asked Questions
More Comparisons
More matchups featuring qXR-CTR or Eko Low Ejection Fraction Tool (ELEFT)
Backers
Who funded each tool's parent company.